Mercury Pharma Group

Large enterpriseCompany No. 02330913

Has won 17 UK public-sector contracts across 1 buyer, primarily The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS).

⇄ Compare peers ⇩ Export ↗ Share

Active contracts

no new awards in 30d

Contracted (12m)

—

no data

Public buyers

stable this month

Top buyer share

—

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracts won · 17 total · 17 active · 0 expired

Every contract award published under the Procurement Act.

Sort

Title	Buyer	Award type	Value	Awarded	Status
NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood Medicine	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 42 suppliers	—	active
NP35923 Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 3 suppliers	—	active
NP35923 Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 5 suppliers	—	active
NP35923 Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 39 suppliers	—	active
Generic and Biosimilar Cancer Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 23 suppliers	—	active
Generic and Biosimilar Cancer Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Direct contract	—	—	active
NP37122 ENT, Ophthalmology & Skin Medicines/Medical Devices	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 16 suppliers	—	active
NP37122 ENT, Ophthalmology & Skin Medicines/Medical Devices	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 30 suppliers	—	active
Antibiotic, Antiviral & Genito Urinary Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 35 suppliers	—	active
Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 31 suppliers	—	active
Psychiatry Generic Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 7 suppliers	—	active
Psychiatry Generic Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 32 suppliers	—	active
Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 39 suppliers	—	active
Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 38 suppliers	—	active
Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 7 suppliers	—	active

Showing 1–15 of 17

Mercury Pharma Group

Contracts won · 17 total · 17 active · 0 expired

Top buyers · by total award value

Category mix — CPV divisions

Geographic spread

Modifications received · scope growth on existing wins

Compliance scorecard

Financial health

Company information

Corporate structure

Companies House data

Peer suppliers

News mentions

Compliance scorecard

Financial health

Company information

Corporate structure

Mercury Pharma Group

Companies House data

Why Capita's public-sector share keeps slipping — and who's eating it

The 12 frameworks Capita bid on last year (and lost 8)

Is BPO concentration back? A supplier-risk deep-dive